Orthopedic DVT/PE Prophylaxis Practices

Despite the existence of evidence-based guidelines, DVT/PE prophylaxis practices reported by THA/TKA surgeons participating in NBCA’s survey vary widely: 70% pneumatic compression, 69% ambulation, 58% compression stockings, 47% LMWH, 28% warfarin, 15% LMWH with transition to warfarin, and 14% aspirin.

The survey findings validate the need for interventions to address anticoagulant treatment barriers, and the need to better define optimal DVT/PE prophylaxis for THA and TKA patients to overcome longstanding therapeutic obstacles. This can be accomplished with comparative effectiveness research, combined with consensus building efforts — such as a CDC/NIH Consensus Development Conference, for example — to optimize prophylaxis among at-risk THA/TKA patients.

Prophylaxis Practices
DVT/PE Risk Versus THA/TKA Patient Awareness
Quick Facts
NBCA Survey Methodology

The NBCA DVT/PE Awareness Survey was made possible by a grant from Ortho-McNeil™, a Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Current News

The National Blood Clot Alliance Launches New Council for Emerging Researchers in Thrombosis (CERT)

FOR IMMEDIATE RELEASE: 07/28/2022   The National Blood Clot Alliance (NBCA), the nation’s leading nonprofit patient advocacy organization dedicated to…

The FUVID Study

The FUVID Study (Functional Characterization of Chronic Thromboembolic Venous Disease in Children) is currently open for enrollment to qualified participants.…